Developing a new treatment for tuberculosis called Telacebec.
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS
['FUNDING_OTHER'] · MIDWEST RESEARCH INSTITUTE · NIH-11219854
This study is testing a new medication called Telacebec (Q203) to see if it can help people with tuberculosis by making treatment safer and more effective, which could lead to shorter recovery times and better health outcomes.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MIDWEST RESEARCH INSTITUTE (nih funded) |
| Locations | 1 site (KANSAS CITY, UNITED STATES) |
| Trial ID | NIH-11219854 on ClinicalTrials.gov |
What this research studies
This research focuses on the development of Telacebec (Q203), a new medication aimed at treating tuberculosis. The project involves supporting the chemistry, manufacturing, and controls necessary to ensure the drug is safe and effective for patients. By refining the processes involved in creating this treatment, the research aims to improve the overall management of tuberculosis infections. Patients may benefit from a more effective therapy that could potentially shorten treatment duration and improve outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with tuberculosis, particularly those who may not respond well to existing treatments.
Not a fit: Patients with non-tuberculosis infections or those who do not have a confirmed diagnosis of tuberculosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a more effective treatment option for tuberculosis.
How similar studies have performed: Other research has shown promise in developing new tuberculosis treatments, but the specific approach of Telacebec is relatively novel.
Where this research is happening
KANSAS CITY, UNITED STATES
- MIDWEST RESEARCH INSTITUTE — KANSAS CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SLADE, DESMOND — MIDWEST RESEARCH INSTITUTE
- Study coordinator: SLADE, DESMOND
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: M tuberculosis infection, M. tb infection, M. tuberculosis infection, M.tb infection, M.tuberculosis infection